TY - JOUR
T1 - Glycaemia (haemoglobin A1c) and incident ischaemic stroke
T2 - The Atherosclerosis Risk in Communities (ARIC) Study
AU - Selvin, Elizabeth
AU - Coresh, Josef
AU - Shahar, Eyal
AU - Zhang, Lin
AU - Steffes, Michael
AU - Sharrett, A. Richey
N1 - Funding Information:
We thank the staff and participants of the ARIC study for their important contributions. E Selvin was supported by NHLBI grant T32HL07024. The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, and N01-HC-55022.
PY - 2005/12
Y1 - 2005/12
N2 - Background: Individuals with diabetes have a raised risk of stroke, but it is unclear whether sustained hyperglycaemia contributes to the development of cerebrovascular disease. Haemoglobin A1c (HbA1c), a measure of long-term glycaemia, is strongly related to retinopathy, nephropathy, and neuropathy in diabetes. We sought to assess the association between HbA 1c and stroke in people with and without diabetes. Methods: 10 886 participants without diabetes and 1635 participants with diabetes in the ARIC study, who did not have cardiovascular disease, were followed up for incident ischaemic stroke over 8-10 years. We assayed HbA1c for all 167 stroke cases and a sample of 680 non-cases in the adults without diabetes and for the full cohort of 1635 adults with diabetes (including 89 stroke cases). We assessed the relation between HbA1c concentrations (in tertiles specific for individuals with and without diabetes) and incident ischaemic stroke during follow-up using Cox proportional hazards models, controlling for risk factors for stroke. Findings: The adjusted relative risks of stroke increased with increasing tertile of HbA1c in both adults without diabetes (p=0·02) and with diabetes (p<0·0001). Compared with adults without diabetes in the lowest tertile of HbA1c, the adjusted relative risks of stroke by HbA1c tertile were 1·18 (0·70-2·00) and 1·58 (0·94-2·66) in adults without diabetes and 1·75 (0·90-3·42), 2·29 (1·24-4·21), and 4·71 (2·69-8·25) in adults with diabetes. Interpretation: Raised HbA1c could be an independent risk factor for stroke in people with and without diabetes, with relative risks similar to those previously reported for coronary heart disease.
AB - Background: Individuals with diabetes have a raised risk of stroke, but it is unclear whether sustained hyperglycaemia contributes to the development of cerebrovascular disease. Haemoglobin A1c (HbA1c), a measure of long-term glycaemia, is strongly related to retinopathy, nephropathy, and neuropathy in diabetes. We sought to assess the association between HbA 1c and stroke in people with and without diabetes. Methods: 10 886 participants without diabetes and 1635 participants with diabetes in the ARIC study, who did not have cardiovascular disease, were followed up for incident ischaemic stroke over 8-10 years. We assayed HbA1c for all 167 stroke cases and a sample of 680 non-cases in the adults without diabetes and for the full cohort of 1635 adults with diabetes (including 89 stroke cases). We assessed the relation between HbA1c concentrations (in tertiles specific for individuals with and without diabetes) and incident ischaemic stroke during follow-up using Cox proportional hazards models, controlling for risk factors for stroke. Findings: The adjusted relative risks of stroke increased with increasing tertile of HbA1c in both adults without diabetes (p=0·02) and with diabetes (p<0·0001). Compared with adults without diabetes in the lowest tertile of HbA1c, the adjusted relative risks of stroke by HbA1c tertile were 1·18 (0·70-2·00) and 1·58 (0·94-2·66) in adults without diabetes and 1·75 (0·90-3·42), 2·29 (1·24-4·21), and 4·71 (2·69-8·25) in adults with diabetes. Interpretation: Raised HbA1c could be an independent risk factor for stroke in people with and without diabetes, with relative risks similar to those previously reported for coronary heart disease.
UR - http://www.scopus.com/inward/record.url?scp=27744437538&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=27744437538&partnerID=8YFLogxK
U2 - 10.1016/S1474-4422(05)70227-1
DO - 10.1016/S1474-4422(05)70227-1
M3 - Article
C2 - 16297840
AN - SCOPUS:27744437538
SN - 1474-4422
VL - 4
SP - 821
EP - 826
JO - The Lancet Neurology
JF - The Lancet Neurology
IS - 12
ER -